Venetoclax 400
HO173
Phase 3 small_molecule active
Quick answer
Venetoclax 400 for Acute Myeloid Leukemia is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active